Suppr超能文献

辐射联合SU5416:人异种移植胶质母细胞瘤肿瘤系中的微血管变化与生长延迟

Irradiation combined with SU5416: microvascular changes and growth delay in a human xenograft glioblastoma tumor line.

作者信息

Schuuring Janneke, Bussink Johan, Bernsen Hans J J A, Peeters Wenny, van Der Kogel Albert J

机构信息

Department of Neurology, University Medical Center, Nijmegen, The Netherlands.

出版信息

Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):529-34. doi: 10.1016/j.ijrobp.2004.09.063.

Abstract

PURPOSE

The combination of irradiation and the antiangiogenic compound SU5416 was tested and compared with irradiation alone in a human glioblastoma tumor line xenografted in nude mice. The aim of this study was to monitor microenvironmental changes and growth delay.

METHODS AND MATERIALS

A human glioblastoma xenograft tumor line was implanted in nude mice. Irradiations consisted of 10 Gy or 20 Gy with and without SU5416. Several microenvironmental parameters (tumor cell hypoxia, tumor blood perfusion, vascular volume, and microvascular density) were analyzed after imunohistochemical staining. Tumor growth delay was monitored for up to 200 days after treatment.

RESULTS

SU5416, when combined with irradiation, has an additive effect over treatment with irradiation alone. Analysis of the tumor microenvironment showed a decreased vascular density during treatment with SU5416. In tumors regrowing after reaching only a partial remission, vascular characteristics normalized shortly after cessation of SU5416. However, in tumors regrowing after reaching a complete remission, permanent microenvironmental changes and an increase of tumor necrosis with a subsequent slower tumor regrowth was found.

CONCLUSIONS

Permanent vascular changes were seen after combined treatment resulting in complete remission. Antiangiogenic treatment with SU5416 when combined with irradiation has an additive effect over treatment with irradiation or antiangiogenic treatment alone.

摘要

目的

在裸鼠体内异种移植的人胶质母细胞瘤肿瘤模型中,测试放疗与抗血管生成化合物SU5416联合使用的效果,并与单纯放疗进行比较。本研究的目的是监测微环境变化和生长延迟情况。

方法与材料

将人胶质母细胞瘤异种移植肿瘤模型植入裸鼠体内。放疗剂量为10 Gy或20 Gy,分别联合或不联合SU5416。免疫组织化学染色后分析多个微环境参数(肿瘤细胞缺氧、肿瘤血流灌注、血管体积和微血管密度)。治疗后长达200天监测肿瘤生长延迟情况。

结果

SU5416与放疗联合使用时,相对于单纯放疗具有相加作用。肿瘤微环境分析显示,在使用SU5416治疗期间血管密度降低。在仅达到部分缓解后复发的肿瘤中,停止使用SU5416后不久血管特征恢复正常。然而,在达到完全缓解后复发的肿瘤中,发现有永久性微环境变化以及肿瘤坏死增加,随后肿瘤复发速度减慢。

结论

联合治疗导致完全缓解后可见永久性血管变化。SU5416与放疗联合进行抗血管生成治疗相对于单纯放疗或抗血管生成治疗具有相加作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验